Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers (Q39164373)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 May 2013
edit
Language Label Description Also known as
English
Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers
scientific article published on 25 May 2013

    Statements

    Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers (English)
    25 May 2013
    2234-2244

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit